BTC Neuropsychological Database:Prospective Study
Study Activities and Population Group:
Retrospective dates will be 3/1/06 through the approval date for the prospective component
of this study. The data will be neurocognitive, depression, tumor-related, overall quality
of life (QOL), treatment, and demographic variables. The investigators research aims are to
- compute correlations among these different variables
- to test significant predictors of QOL. The investigators also will conduct a
retrospective review of all brain tumor patients evaluated at the neuropsychology
clinic at the PRT-BTC from the date that this prospective study is approved back to
Data Analysis and Risk/Safety Issues:
The medical record review does not present any obvious source of risk or discomfort to
patients and their families. For both the retrospective and prospective components of the
study, as the data for the proposed study were already collected as a part of the standard
of care at the Preston Robert Tisch Brain Tumor Center at Duke, there are no additional
risks to the study sample as a result of data collection.
Observational Model: Cohort
Bivariate correlational analyses will be conducted to examine associations between neuropsychological, depression, demographic, medication data tumor-related treatment , and QoL variables.
Renee Raynor, Ph.D.
United States: Institutional Review Board
|Duke University Medical Center||Durham, North Carolina 27710|